Insiders · Profile

HUMPHREY RACHEL

Director at Pyxis Oncology · Chief Medical Officer at CytomX Therapeutics. Filing since 28 Feb 2018. CIK 0001579781

Company
Date
Role
Action
Shares
Amount
Of holding
21 Apr 2025
Director
Sold on a plan
13,896
$14.36K
14.6%
17 Apr 2025
Director
Sold on a plan
200
$194.00
0.2%
14 Apr 2025
Director
Sold on a plan
1,400
$1.36K
1.4%
2 Mar 2018
Chief Medical Officer
Sold, plan not stated
16,160
$484.80K
34.8%
28 Feb 2018
Chief Medical Officer
Sold, plan not stated
23,840
$715.20K
44.1%
5 decisions on file.